Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
BMC Cancer|September 24, 2014
Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasmMichael Boch, Anja Rinke, Peter Rexin, et al.
Gut|September 5, 2018
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?Albrecht Neesse, Christian Alexander Bauer, Daniel Öhlund, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|October 2, 2023
Treatment of esophageal leakages with the Microtech<sup>®</sup>-VAC-Stent: a monocentric early experience of three casesMichelle A Klose, Jens Walldorf, Marko Damm, et al.
Plos One|June 26, 2019
Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cellsSebastian Krug, Jan-Philipp Mordhorst, Fabian Moser, et al.
JMIR Research Protocols|December 13, 2022
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective StudyArtur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2026
Diagnostic Impact of Liver Biopsy Among Antinuclear Antibody Positive Individuals With Mild Liver Enzyme ElevationDavid Mehdi Asgher Niazi, Alphonse Charbel, Jan Pfeiffenberger, et al.
Journal of Patient Experience|July 18, 2022
Pancreatic Cancer From the Patient Perspective: The Time to Act is NowMarianna Vitaloni, Patrick Michl, Matthias Löhr, et al.
Plos One|February 5, 2020
Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cellsSebastian Krug, Jan-Philipp Mordhorst, Fabian Moser, et al.
Neoplasia (New York, N.Y.)|August 7, 2010
Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancerStefanie Ripka, Jan Riedel, Albrecht Neesse, et al.
Annals of Surgery|January 28, 2004
Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemiaRolf J Schauer, Alexander L Gerbes, Daniel Vonier, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
BMC Cancer|September 24, 2014
Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasmMichael Boch, Anja Rinke, Peter Rexin, et al.
Gut|September 5, 2018
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?Albrecht Neesse, Christian Alexander Bauer, Daniel Öhlund, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|October 2, 2023
Treatment of esophageal leakages with the Microtech<sup>®</sup>-VAC-Stent: a monocentric early experience of three casesMichelle A Klose, Jens Walldorf, Marko Damm, et al.
Plos One|June 26, 2019
Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cellsSebastian Krug, Jan-Philipp Mordhorst, Fabian Moser, et al.
JMIR Research Protocols|December 13, 2022
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective StudyArtur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2026
Diagnostic Impact of Liver Biopsy Among Antinuclear Antibody Positive Individuals With Mild Liver Enzyme ElevationDavid Mehdi Asgher Niazi, Alphonse Charbel, Jan Pfeiffenberger, et al.
Journal of Patient Experience|July 18, 2022
Pancreatic Cancer From the Patient Perspective: The Time to Act is NowMarianna Vitaloni, Patrick Michl, Matthias Löhr, et al.
Plos One|February 5, 2020
Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cellsSebastian Krug, Jan-Philipp Mordhorst, Fabian Moser, et al.
Neoplasia (New York, N.Y.)|August 7, 2010
Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancerStefanie Ripka, Jan Riedel, Albrecht Neesse, et al.
Annals of Surgery|January 28, 2004
Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemiaRolf J Schauer, Alexander L Gerbes, Daniel Vonier, et al.
Pageof 16